Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Healthcare Industry News Can Ping An Biomedical regain compliance before May 2026? What investors should know Ping An Biomedical faces Nasdaq delisting risk after falling below $1 per share. Find out what this means for investors and what could happen next. byPallavi MadhirajuNovember 28, 2025